Anti-Daunomycin Aptamer(Cat#: CTMM-0422-MM9)
This product is an aptamer which binds to the Daunomycin with an affinity of <300 nM.
Specific Inquiry 
Summary
Specifications
| Target Category |
Small Organic |
| Target |
Daunomycin |
| Alternative Names |
Daunorubicin |
| Target Overview |
Daunorubicin, also known as daunomycin, is a chemotherapy medication used to treat cancer. Specifically it is used for acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), and Kaposi's sarcoma. |
| Chemical Modification |
DNA |
| Length |
20-40 nt |
| Affinity (Kd) |
<300 nM |
| Binding Conditions/Buffer |
20 mM Tris-HCl (pH 7.4), 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl22, and 0.05% v/v Tween-20. |
| GC Content |
0.5676 |
| Molecular Weight |
11581.57 g/mole |
| Extinction Coefficient |
366800 L/(mole·cm) |
| nmoles/OD260 |
2.73 |
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
